Group 1 - The company, Yidu Tech (02158), announced a share buyback plan on January 30, 2026, involving an expenditure of HKD 4.5579 million to repurchase 786,300 shares [1] - The buyback price is set between HKD 5.72 and HKD 6.00 per share [1]

格隆汇1月30日丨医渡科技(02158.HK)公告，1月30日耗资455.8万港元回购78.6万股。 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 醫渡科技有限公司 呈交日期： 2026年1月30日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02158 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | | 佔有關事件 ...

Core Insights - Shenzhen Nanshan District People's Hospital and Yidu Technology have established a strategic partnership to launch an "AI + Health Management" innovative system, aiming to create a closed-loop AI medical ecosystem covering "full-time, full-domain, full-population, and full-cycle" [1][3] Group 1: Strategic Collaboration - The collaboration aims to leverage Yidu Technology's AI capabilities to build a comprehensive health service system that enhances the medical service model and improves public health outcomes [3][4] - The partnership will focus on constructing an "AI Parallel Hospital" and a "24-hour Digital Research Institute," exploring compliant development of medical data elements [4] Group 2: Digital Transformation in Healthcare - The innovative system will integrate clinical diagnosis and health management, providing intelligent services throughout the entire patient journey, from prevention to rehabilitation [3][5] - Yidu Technology's CEO emphasized the company's commitment to empowering the digital transformation of Shenzhen's healthcare industry through systematic capabilities in medical data governance and AI platform construction [5][6] Group 3: Implementation and Future Prospects - The collaboration is expected to enhance hospital operational efficiency, optimize patient service experiences, and strengthen health management capabilities [6][7] - Shenzhen aims to contribute to the intelligent upgrade of the healthcare industry in the Greater Bay Area by exploring replicable paths and providing a "Shenzhen practice" model for digital transformation [7]

Group 1 - The company, Yidu Tech (02158), announced a share buyback on January 28, repurchasing 121,800 shares at approximately HKD 6 per share, totaling around HKD 730,000. This marks the fourth consecutive trading day of buybacks, with a total of approximately 830,000 shares repurchased and nearly HKD 5 million spent, signaling confidence to the market [1] - The company has achieved significant progress in business expansion and product implementation, with the number of participants in the 2026 "Beijing Universal Health Insurance" exceeding 4.5 million. As the main operating platform for this project for five consecutive years, Yidu Tech demonstrates its operational strength and market recognition [1] - Yidu Tech has made breakthroughs in the application of AI in primary healthcare, with the "General Medicine Diagnosis AI Assistant" developed in collaboration with Chongqing Medical University First Affiliated Hospital being implemented in over 20 grassroots medical institutions in Chongqing since its trial run in May 2025, serving more than 1,000 healthcare professionals [1]

Core Viewpoint - The company, Yidu Tech (02158), is actively engaging in share buybacks to instill market confidence while simultaneously achieving significant progress in business expansion and product implementation [1] Group 1: Share Buyback Activity - On January 28, Yidu Tech announced a share buyback of approximately 121,800 shares at around HKD 6 per share, costing about HKD 730,000 [1] - The company has conducted buybacks for four consecutive trading days, totaling approximately 830,000 shares and nearly HKD 5 million in expenditure [1] Group 2: Business Expansion - The number of participants in the 2026 "Beijing Universal Health Insurance" program, which Yidu Tech operates, has surpassed 4.5 million [1] - Yidu Tech has been the main operating platform for this project for five consecutive years, demonstrating its operational strength and market recognition [1] Group 3: Technological Advancements - Yidu Tech has made breakthroughs in the application of AI in healthcare, specifically with the "General Medicine Diagnosis AI Assistant" developed in collaboration with Chongqing Medical University [1] - Since its trial run in May 2025, the AI assistant has been implemented in over 20 grassroots medical institutions in Chongqing, serving more than 1,000 healthcare professionals [1]

医渡科技(02158)公布，2026年1月29日耗资约72.82万港元回购12.18万股股份。 ...

智通财经APP讯，医渡科技(02158)公布，2026年1月29日耗资约72.82万港元回购12.18万股股份。 ...

格隆汇1月29日丨医渡科技(02158.HK)公告，1月29日耗资72.8万港元回购12.2万股。 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 醫渡科技有限公司 呈交日期： 2026年1月29日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02158 | 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | 佔有關事件前的現有已發 行股份（不包括庫存股 ...